Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
How B12 injections works
This peptide is not FDA approved, and there is no human safety data
In the first year following diagnosis, we found increased cumulative incidence risk ratios in a number of outcomes including: - Any mental, behavioural, or neurodevelopmental disorder 1.96 (1.93 - 1.99) - Postpartum depression 2.70 (2.61 - 2.79) - Eating disorders 2.06 (1.85 - 2.89) - PTSD 1.77 (1.69 - 1.86) We also saw significantly increased risk in rare but serious outcomes such as: - Wernicke's encephalopathy 2.39 (1.25 - 4.56) - Puerperal psychosis 1.80 (1.48 - 2.20) Interestingly, cases of hyperemesis gravidarum with metabolic disturbance displayed a significantly lower risk of any depression and postpartum depression compared with those without metabolic disturbance
Overall, this significant discovery highlights the potential of using CpG methylation patterns as diagnostic biomarkers for neurodegenerative conditions characterized by CCL11 upregulation
US$ 27.43
US$ 28.58
US$ 20.97
US$ 28.40
US$ 25.09